Menu
Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 9 » Issue 1
Original Research
Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2–4 COPD: results from two replicate 48-week studies
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 22,713 | Dovepress* | 18,235+ | 3,420 | 21,655 | |
| PubMed Central* | 4,478 | 2,051 | 6,529 | ||
| Totals | 22,713 | 5,471 | 28,184 | ||
|
*Since 5 July 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 0 | 2 |
View citations on PubMed Central and Google Scholar